コンテンツへスキップ

CrestecBio|News

  • Home
News

Our project was adopted as a candidate for the Strategic Innovation Program (SIP).

Bynews

9月 27, 2022

Our project was adopted as a candidate for the Strategic Innovation Program (SIP) of the Cabinet Office for The feasibility study “Development of Basic Technology for Material Process Innovation”.

投稿ナビゲーション

CrestecBio Inc. was adopted for the 2022 Ibaraki Prefecture Venture Business Growth Promotion Project (Growth Program).
CrestecBio Inc. (Head office: Tsukuba, Ibaraki Prefecture, Japan; CEO: Aiki Marushima) has raised funds through the issuance of J-KISS type stock acquisition rights to Newsight Tech Angels, Inc.

By news

Related Post

News

Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.

5月 25, 2025 news_en
News

Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.

5月 16, 2025 news_en
News

An interview with our CEO, Marushima, has been featured on the “Startup Magazine” website by Startup Class Inc. (in Japanese)

5月 12, 2025 news_en

Recent Posts

  • Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.
  • Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.
  • An interview with our CEO, Marushima, has been featured on the “Startup Magazine” website by Startup Class Inc. (in Japanese)
  • Our CEO, Dr. Marushima, will attend BIO International Convention 2025 in Boston.
  • Dr. Marushima presented at Tokyo Investors Night.

見逃しています

News

Our Scientific Advisor, Dr. Yukio Nagasaki, has been awarded the Academic Award from the Japanese Society of Oxidative Stress and the Achievement Award from The Society of Polymer Science, Japan.

2025-05-25 news_en
News

Our CEO, Dr. Marushima will attend The 31st Annual Meeting of the Japanese Society for Endovascular Intervention.

2025-05-16 news_en
News

An interview with our CEO, Marushima, has been featured on the “Startup Magazine” website by Startup Class Inc. (in Japanese)

2025-05-12 news_en
News

Our CEO, Dr. Marushima, will attend BIO International Convention 2025 in Boston.

2025-05-10 news_en

CrestecBio|News

  • Home